Navigation Links
Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
Date:5/6/2011

the Common Stock for as long as 20 business days.

It is presently anticipated that the reverse stock split will become effective on or about May 15, 2011. Upon the effectiveness of the reverse stock split, each of the Company's shareholders will receive one new share of Common Stock in exchange for every six shares such shareholder holds. The Common Stock will begin trading on a split-adjusted basis on the Mercato Telematico Azionario stock market (the "MTA") in Italy and The NASDAQ Capital Market in the United States on May 16, 2011. On The NASDAQ Capital Market, trading of the Common Stock will appear under the temporary trading symbol "CTICD" in order to inform the investment community of the reverse stock split. The Company's trading symbol will revert to "CTIC" on or about June 13, 2011.  The Company's trading symbol on the MTA will not change due to the reverse stock split.

The reverse stock split will affect all outstanding and authorized shares of the Common Stock as well as the number of shares of Common Stock underlying stock options and other exercisable or convertible instruments outstanding at the effective time of the reverse stock split.

About Cell Therapeutics, Inc.

Headquartered in Seattle, the Company is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.celltherapeutics.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the Company's securities. Specifically, the risks and uncertainties that could the Company include risks associated with preclinical and clinical developments in the biopharmaceutical industry, including, without limitation, that
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... 2015 The U.S. Food and Drug Administration ... ReShape Integrated Dual Balloon System, that may help fill ... with obesity and one or more obesity-related conditions, according ... (ASMBS), the nation,s largest organization for bariatric surgeons. ... review the FDA has approved this new device for ...
(Date:7/29/2015)... 29, 2015  Shareholder rights law firm Robbins ... officers and directors of AMAG Pharmaceuticals, Inc. (NASDAQGS: ... Pharmaceuticals operates as a specialty pharmaceutical company that ... care.  The company markets Makena, a hydroxyprogesterone caproate ... in women with a singleton pregnancy. ...
Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2
... Sept. 22, 2011 Biodel Inc. (Nasdaq: BIOD ... Chief Executive Officer, will be presenting at the 6th Annual ... New York.  The presentation is scheduled for Tuesday, September 27, ... to the live webcast or a replay of the presentation, ...
... Sept. 22, 2011 Reportlinker.com announces that ... in its catalogue: Generic ... http://www.reportlinker.com/p0619265/Generic-Drugs-The-Global-Market--Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment ... * An examination of the strategies employed ...
Cached Medicine Technology:Generic Drugs: The Global Market--Focus on Europe 2Generic Drugs: The Global Market--Focus on Europe 3Generic Drugs: The Global Market--Focus on Europe 4Generic Drugs: The Global Market--Focus on Europe 5Generic Drugs: The Global Market--Focus on Europe 6Generic Drugs: The Global Market--Focus on Europe 7Generic Drugs: The Global Market--Focus on Europe 8Generic Drugs: The Global Market--Focus on Europe 9Generic Drugs: The Global Market--Focus on Europe 10
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide ... St. John’s Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh ... more than 25 years of healthcare leadership experience, Walsh is an expert in organizational ...
(Date:7/30/2015)... Beverly Hills, CA (PRWEB) , ... July 30, 2015 , ... ... safety of the Argus II retinal implant, more commonly known as the “bionic eye,” ... II as a safe and viable tool for patients facing or already affected by ...
(Date:7/30/2015)... ... , ... HEALTHCAREfirst , the leading provider of cloud-based software, services and ... a free webinar detailing the 2016 proposed rule from CMS for home health. , ... of Regulatory Affairs for the National Association for Home Care and Hospice (NAHC), and ...
(Date:7/30/2015)... ... July 30, 2015 , ... The renowned ... grants in its history of funding brain aneurysm research. , Each year, ... life’s work toward scientific research directed at early detection, improved treatment modalities, and ...
(Date:7/30/2015)... Orem, UT (PRWEB) , ... July 30, 2015 , ... When trying to gain weight, many people place a lot ... the amount of calories that need to be consumed. However, another key component to successful ... to gain weight. To assist with this, CB-1 Weight Gainer gives three tips on ...
Breaking Medicine News(10 mins):Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3
... , , MOUNTAIN VIEW, Calif., Sept. 16 ... Hospital CEO, Ken Graham, will provide insight on health care reform at ... 17 at 7:15 a.m. at the Rotary Summit Center. , , ... contribute to the health care reform debate. El Camino Hospital, a non-profit ...
... , REDMOND, Wash., Sept. 16 It,s ... seats in classrooms and lecture halls because of unfortunate outbreaks of ... to the U.S. Department of Education and schools and universities across ... educators stay connected with their students and continue the learning process ...
... , www.intelligenthospitals.com , , WINNIPEG, Sept. ... of pharmacy across North America, 77% of those looking ... (Robotic Intravenous Automation) - a self-contained unit for filling ... Systems) - as a vendor under consideration. The survey ...
... , , WASHINGTON, Sept. 16 ... CEO of the American Legacy Foundation: , , The ... U.S. House of Representatives who have worked tirelessly to protect Capitol Hill ... , On Thursday, the House,s last two indoor smoking ...
... , NEW YORK, Sept. 16 HMS today announced ... of Human Services (DHS) to provide additional third-party liability services. With ... to 39 state Medicaid agencies. , , "Under ... Billi Jo Zielinski, Assistant Commissioner of Health Care. "This will help ...
... , WASHINGTON, Sept. 16 The U.S. Food and ... a boxed warning regarding the injectable form of the drug. The ... the risk of serious tissue injury when this drug is administered ... new boxed warning for this product, which is used as a ...
Cached Medicine News:Health News:El Camino Hospital Provides Local Perspective on Health Care Reform and Innovation at Silicon Valley Healthcare CEO Summit 2Health News:Microsoft Gives Teachers Free Resources to Address Classroom Challenges Due to the Impact of H1N1 Flu Virus 2Health News:Microsoft Gives Teachers Free Resources to Address Classroom Challenges Due to the Impact of H1N1 Flu Virus 3Health News:IH Systems RIVA Top Pick for Directors of Pharmacy 2Health News:Congress Breathes Easier, Thanks to Speaker Pelosi's Successful Efforts to Eliminate House Smoking Rooms 2Health News:FDA Requires Boxed Warning for Promethazine Hydrochloride Injection 2